📣 VC round data is live. Check it out!
- Public Comps
- Alzchem Group
Alzchem Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Alzchem Group and similar public comparables like Ingevity, MOPCO, Innospec, Saudi Chemical and more.
Alzchem Group Overview
About Alzchem Group
Alzchem Group AG is an international chemical company. The reportable segments of the company are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from Germany.
Founded
1908
HQ

Employees
1.7K
Website
Sectors
Financials (LTM)
EV
$2B
Valuation Multiples
Start free trialAlzchem Group Financials
Alzchem Group reported last 12-month revenue of $680M and EBITDA of $143M.
In the same LTM period, Alzchem Group generated $444M in gross profit, $143M in EBITDA, and $76M in net income.
Revenue (LTM)
Alzchem Group P&L
In the most recent fiscal year, Alzchem Group reported revenue of $663M and EBITDA of $139M.
Alzchem Group is profitable as of last fiscal year, with gross margin of 68%, EBITDA margin of 21%, and net margin of 11%.
Financial data powered by Morningstar, Inc.
Alzchem Group Stock Performance
Alzchem Group has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Alzchem Group's stock price is $217.23.
Alzchem Group share price decreased by 1.5% in the last 30 days, and increased by 36.2% in the last year.
Alzchem Group has an EPS (earnings per share) of $7.42.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | -1.4% | -1.5% | 8.7% | 36.2% | $7.42 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAlzchem Group Valuation Multiples
Alzchem Group trades at 3.2x EV/Revenue multiple, and 15.2x EV/EBITDA.
EV / Revenue (LTM)
Alzchem Group Financial Valuation Multiples
As of June 3, 2026, Alzchem Group has market cap of $2B and EV of $2B.
Alzchem Group has a P/E ratio of 28.9x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Alzchem Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Alzchem Group Margins & Growth Rates
Alzchem Group grew revenue by 6% and EBITDA by 8% in the last fiscal year.
In the most recent fiscal year, Alzchem Group reported gross margin of 68%, EBITDA margin of 21%, and net margin of 11%.
Alzchem Group Margins
Alzchem Group Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Alzchem Group Operational KPIs
Alzchem Group's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Alzchem Group's Rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Alzchem Group's Rule of X is 40% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Alzchem Group Competitors
Alzchem Group competitors include Ingevity, MOPCO, Innospec, Saudi Chemical, OQ Base Industries, Abu Qir Fertilizers, Saudi Kayan, Robertet, Teijin and Solvac.
Most Alzchem Group public comparables operate across Chemicals.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 3.0x | 3.1x | 8.8x | 8.9x | |||
| 4.0x | 3.2x | 7.0x | 5.7x | |||
| 1.0x | 1.0x | 8.7x | 8.9x | |||
| 1.2x | - | 15.1x | - | |||
| 4.8x | 4.5x | 10.9x | 11.6x | |||
| 2.8x | 1.6x | 6.2x | 3.2x | |||
| 2.1x | 2.1x | 24.7x | 18.3x | |||
| 2.0x | 2.0x | 9.9x | 10.0x | |||
This data is available for Pro users. Sign up to see all Alzchem Group competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Alzchem Group
| When was Alzchem Group founded? | Alzchem Group was founded in 1908. |
| Where is Alzchem Group headquartered? | Alzchem Group is headquartered in Germany. |
| How many employees does Alzchem Group have? | As of today, Alzchem Group has over 1K employees. |
| Is Alzchem Group publicly listed? | Yes, Alzchem Group is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of Alzchem Group? | Alzchem Group trades under ACT ticker. |
| When did Alzchem Group go public? | Alzchem Group went public in 2011. |
| Who are competitors of Alzchem Group? | Alzchem Group main competitors include Ingevity, MOPCO, Innospec, Saudi Chemical, OQ Base Industries, Abu Qir Fertilizers, Saudi Kayan, Robertet, Teijin, Solvac. |
| What is the current market cap of Alzchem Group? | Alzchem Group's current market cap is $2B. |
| What is the current revenue of Alzchem Group? | Alzchem Group's last 12 months revenue is $680M. |
| What is the current revenue growth of Alzchem Group? | Alzchem Group revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of Alzchem Group? | Current revenue multiple of Alzchem Group is 3.2x. |
| What is the current EBITDA of Alzchem Group? | Alzchem Group's last 12 months EBITDA is $143M. |
| What is Alzchem Group's EBITDA margin? | Alzchem Group's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Alzchem Group? | Current EBITDA multiple of Alzchem Group is 15.2x. |
| What is the current FCF of Alzchem Group? | Alzchem Group's last 12 months FCF is $60M. |
| What is Alzchem Group's FCF margin? | Alzchem Group's last 12 months FCF margin is 9%. |
| What is the current EV/FCF multiple of Alzchem Group? | Current FCF multiple of Alzchem Group is 35.9x. |
| How many companies Alzchem Group has acquired to date? | Alzchem Group hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Alzchem Group has invested to date? | Alzchem Group hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Alzchem Group
Lists including Alzchem Group
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.